Hemp for Health Consolidates Its Share Capital

Vancouver, British Columbia--(Newsfile Corp. - November 29, 2021) - Further to its news release of November 17, 2021, HEMP FOR HEALTH INC. (CSE: HFH) (FSE: 9HH) (the "Company") announces that effective at the opening of trading on Thursday, December 2^nd, 2021 (the "Effective Date") the shares of the Company will commence trading on the Canadian Securities Exchange (the "Exchange") on a consolidated basis, with one (1) new common share being issued for every two pre-consolidated shares (the "Consolidation").

As a result of the Consolidation, on the Effective Date, a total of 12,081,500 common shares will be issued and outstanding, subject to adjustments for rounding, with 4,264,500 warrants outstanding. No fractional shares will be issued. The name of the Company has not been changed, and the trading symbol remains as "HFH"). A New CUSIP number has been issued, being 42371G206.

Following the Consolidation, the Company intends to complete its previously announced private placement raising up to $1.2 million through the issuance of up to 24,000,000 units ("Unit") at a price of $0.05 per Unit (the "Financing"). Each Unit will consist of one post-consolidated share and one-half of one common share purchase warrant ("Warrant"), with each whole Warrant entitling the holder to purchase one post-consolidated share at $0.10 per share for a period of 24 months from closing. The Company will also be settling certain outstanding debt with various creditors in the aggregate amount of $400,125 through the issuance of up to 8,002,500 post-consolidated shares at a post-consolidated price of $0.05 per share (the "Debt Settlement"). (See news releases dated November 17 and 26, 2021.)

ON BEHALF OF HEMP FOR HEALTH INC.

(sgd.)" Robert Eadie

President & CEO

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

FOR FURTHER INFORMATION PLEASE CONTACT: Robert Eadie
Telephone: 604-602-4935
Toll Free: 1-866-602-4935
Email: [email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/105299

You May Also Be Interested In

• SAGA Metals Reports Assays from R-0058 to R-0060 with Intercepts Including 43.86% Fe2O3, 6.10% TiO2, 0.317% V2O5 from 2026 Drilling at Radar Critical Minerals Project in Labrador and Adds to Its Advis
• XRP Price Prediction: $1 Support Comes Into Focus as AlphaPepe’s Stage 20 Scarcity Gives Retail a Faster Repricing Catalyst
• AB Science announces today the successful completion of capital increases of a total gross amount of EUR 14.2 million